IART vs NXPI · rev $1.64B vs P/E 29, rev $12.27B
Integra LifeSciences Holdings (IART) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported IART revenue for 2025-12-31 was $1.64B. Net income was -$516.5M. IART currently screens at market cap $1.32B.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
IART currently screens at market cap $1.32B. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the IART and NXPI stock pages for the full models.
Not investment advice.